[{"NetIncomeLoss_3_Q3_USD":-203780000.0,"CostOfGoodsAndServicesSoldAmortization_1_Q3_USD":2565000.0,"CostOfGoodsAndServicesSoldAmortization_3_Q3_USD":3239000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":20822000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":1245000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":0.0,"OperatingCostsAndExpenses_1_Q3_USD":80963000.0,"OperatingCostsAndExpenses_3_Q3_USD":199385000.0,"PaymentsToAcquireShortTermInvestments_3_Q3_USD":239821000.0,"DerivativeLiabilitiesCurrent_0_Q3_USD":3163000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":37659000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":13925000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":60526740.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":56233093.0,"ConvertibleLongTermNotesPayable_0_Q3_USD":177377000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":5697000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"AssetsCurrent_0_Q3_USD":450105000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":99013000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"PaymentsForDerivativeInstrumentFinancingActivities_3_Q3_USD":28865000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"OperatingLeaseRightOfUseAsset_0_Q3_USD":25446000.0,"ShareBasedCompensation_3_Q3_USD":24574000.0,"Assets_0_Q3_USD":712147000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":425439000.0,"CommonStockSharesIssued_0_Q3_shares":66587713.0,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_3_Q3_USD":108510000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":5600000.0,"InterestExpenseDebtExcludingAmortization_1_Q3_USD":1258000.0,"InterestExpenseDebtExcludingAmortization_3_Q3_USD":3159000.0,"ResearchAndDevelopmentInProcess_3_Q3_USD":11184000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":1000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":48183000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-474000.0,"OperatingLeaseLiability_0_Q3_USD":27493000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-117000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-3000.0,"CommonStockValue_0_Q3_USD":67000.0,"NumberOfReportableSegments_3_Q3_segment":2.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncomeTaxExpenseBenefit_3_Q3_USD":100000.0,"AccountsReceivableNetCurrent_0_Q3_USD":2585000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-146000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-406000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":13983000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":3685000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":38498000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":29130000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":96027000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":-515000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1719000.0,"ShortTermInvestments_0_Q3_USD":96392000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":5931000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q3_USD":78534000.0,"NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_3_Q3_USD":43400000.0,"RevenueRemainingPerformanceObligation_0_Q3_USD":31000000.0,"Liabilities_0_Q3_USD":339294000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1420770000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":23453000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":339439000.0,"OtherAssetsNoncurrent_0_Q3_USD":1154000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":3000000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":3700000.0,"PaymentsToAcquireBusinessesGross_3_Q3_USD":818000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":147000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-203783000.0,"IncreaseDecreaseInInventories_3_Q3_USD":3976000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":435800000.0,"InvestmentIncomeNonoperating_1_Q3_USD":413000.0,"InvestmentIncomeNonoperating_3_Q3_USD":2868000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":337000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":264160000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-81374000.0,"ConvertibleDebtFairValueDisclosures_0_Q3_USD":305300000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":11005000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":5877000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":9190000.0,"AccountsPayableCurrent_0_Q3_USD":7860000.0,"LiabilitiesCurrent_0_Q3_USD":63653000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":7073000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3_Q3_USD":16969000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-116188000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":6005000.0,"Goodwill_0_Q3_USD":144505000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":13925000.0,"AmortizationOfFinancingCosts_1_Q3_USD":96000.0,"AmortizationOfFinancingCosts_3_Q3_USD":230000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":8137000.0,"CommonStockSharesOutstanding_0_Q3_shares":66587713.0,"ProceedsFromConvertibleDebt_3_Q3_USD":287500000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":2492000.0,"InterestExpense_3_Q3_USD":10738000.0,"InterestExpense_1_Q3_USD":4334000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":340684000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":7713000.0,"NetIncomeLoss_1_Q3_USD":-81257000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":14843000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":336000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"IncomeLossAttributableToParent_1_Q3_USD":-81257000.0,"IncomeLossAttributableToParent_3_Q3_USD":-203680000.0,"OperatingLeasePayments_3_Q3_USD":5071000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":168794000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":58649000.0,"StockIssued1_3_Q3_USD":188104000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.119,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":74849000.0,"InterestExpenseDebt_1_Q3_USD":4330000.0,"InterestExpenseDebt_3_Q3_USD":10735000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":3019000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":5476000.0,"PaymentsToAcquireIntangibleAssets_3_Q3_USD":118000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":29883000.0,"LeaseCost_1_Q3_USD":1742000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1047984000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":18470000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":712147000.0,"OperatingLeaseCost_1_Q3_USD":1460000.0,"OperatingLeaseCost_3_Q3_USD":4310000.0,"PreferredStockValue_0_Q3_USD":0.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":10931000.0,"InventoryNet_0_Q3_USD":3976000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_3_Q3_USD":0.0,"OperatingIncomeLoss_1_Q3_USD":-77128000.0,"OperatingIncomeLoss_3_Q3_USD":-195193000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":3835000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":4192000.0,"CommonStockSharesAuthorized_0_Q3_shares":95000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1254000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":24574000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":10677000.0,"AmortizationOfDebtDiscountPremium_3_Q3_USD":7346000.0,"AmortizationOfDebtDiscountPremium_1_Q3_USD":2976000.0,"VariableLeaseCost_1_Q3_USD":282000.0,"VariableLeaseCost_3_Q3_USD":631000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":7576000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_3_Q3_USD":246500000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":1351000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q3_USD":74849000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":425439000.0,"LeaseCost_3_Q3_USD":4941000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1890000.0,"StockholdersEquity_0_Q3_USD":372853000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-1.34,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-3.62,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":723000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":17142000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":3506000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":4040000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":74811000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":8399000.0,"Ticker":"RVNC","CIK":"1479290","name":"REVANCE THERAPEUTICS, INC.","OfficialName":"Revance Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"1265045755.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201109"}]